DM Graham Laboratories

DM Graham Laboratories was a pharmaceutical company specializing in the development and manufacture of generic drug products and providing contract manufacturing services. Based in Hobart, New York, the company established a reputation for its expertise in solid oral dosage forms and the handling of controlled substances. In 1996, the company was acquired by Mallinckrodt for approximately $52 million, which integrated the facility into its generic pharmaceuticals division. The acquisition allowed Mallinckrodt to significantly expand its presence in the generic drug market, particularly in the area of controlled substances. The Hobart site remains a significant manufacturing hub for Mallinckrodt's specialty generics business, now operating under the SpecGx name. During its independent operation, DM Graham Laboratories was a key player in the regional economy of Delaware County, New York.